RDNT

$63.63

Market ClosedAs of Mar 17, 8:00 PM UTC

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$63.63
Potential Upside
5%
Whystock Fair Value$66.81
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryDiagnostics & Research

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.94B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.46
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
1.37%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.67

Recent News

StockStory
Mar 17, 2026

3 Russell 2000 Stocks That Concern Us

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Mar 15, 2026

How Investors Are Reacting To RadNet (RDNT) 2026 AI-Driven Revenue And EBITDA Growth Targets

RadNet, Inc. recently presented at the Barclays 28th Annual Global Healthcare Conference, where CFO Mark Stolper outlined expectations for 2026 revenue growth of 17%–19% and EBITDA growth of 18%–22% driven by advanced imaging and AI-enabled solutions. Despite reporting full-year 2025 revenue of US$2.04 billion alongside a net loss of US$18.65 million, the company is emphasizing AI-enabled imaging and workflow improvements as key levers for improving profitability and strengthening its...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 13, 2026

Why RadNet (RDNT) Stock Is Up Today

Shares of diagnostic imaging company RadNet (NASDAQ:RDNT) jumped 3.4% in the afternoon session after the company presented a robust strategic outlook at the Barclays 28th Annual Global Healthcare Conference, projecting strong growth for 2026.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 13, 2026

1 Cash-Burning Stock with Exciting Potential and 2 We Ignore

While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to significant downside.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
StockStory
Mar 6, 2026

AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know

A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.

BEARISH
Negative press. News cycle fixated on risk factors or misses.